AI Innovation Purpose-Built for Specialized Life Sciences
Moving beyond the "one-size-fits-all" approach of pharmaceutical AI. HubMed provides a modular ecosystem tailored for the unique scientific and regulatory landscapes of Nutraceuticals, Cosmetics, Medical Devices, and CROs. Accelerate discovery and ensure compliance with the Swiss authority in non-pharma R&D.
Explore Nutraceuticals Explore Medical Devices Explore Cosmetics Explore CROs
Bridging the Gap Between Scientific Innovation and Market SuccessBody
Innovation in specialized life sciences is often bottlenecked by fragmented data and increasing regulatory scrutiny. HubMed solves these challenges by providing a unified digital thread that spans from early-stage compound discovery to final audit defense.
Targeted Compound Discovery
Rapidly identify bioactive compounds for health claims and skincare innovation.
Automated Regulatory Defense
Navigate the complex transition to MDR and IVDR with AI-powered literature surveillance and GSPR mapping.
Digital Traceability
Replace manual documentation with a secure "Swiss Vault" that ensures 100% audit-readiness.
Our Core Sectors
Nutraceuticals | Bioactive Innovation
Focus: Identifying innovative ingredients and validating health claims with speed and scientific rigor.
Accelerate the identification of bioactive compounds from vast molecular libraries.
Ensure all claims are backed by distilled, evidence-based insights.
Cosmetics | Sustainable Safety
Focus: Developing next-generation skincare through in-silico safety profiling.
Leverage AI as a sustainable alternative to traditional animal testing.
Identify breakthrough ingredients while ensuring 100% toxicological compliance.
Medical Devices | Compliance Done Right
Focus: Navigating the 7-step conformity assessment and mastering the MDR/IVDR pathway.
Automate Clinical Evaluation Reports (CER) and State of the Art (SOTA) analysis.
Bridge the gap between clinical data and Annex I GSPR requirements.
CROs | Operational Efficiency
Focus: Delivering "NB-Ready" documentation and reducing Notified Body feedback loops.
Eliminate the 30% rejection rate of CERs through automated completeness checks.
Boost profitability by reducing manual literature monitoring time by 70%.
Resolving Complexity. Ensuring Compliance.
Whether you are an R&D team at an emerging biotech or a global CRO, the stakes are high. A single documentation gap can lead to years of certification delay and millions in lost revenue. HubMed provides the precision and reliability needed to protect your market access.
Frequently asked questions
Here are some common questions about Industry Specifics.
HubMed automates the complex transition documentation required for legacy devices, supporting extensions through 2027/2029 to ensure continuous market availability.
Yes. HubMed is designed to scale across all risk classes, from Class I to high-risk Class III devices, ensuring that even the most complex technical files meet Notified Body standards.
Our platform utilizing the PICO framework and structured evidence generation allows you to create a "source of truth" that can be adapted for both FDA pre-market approvals and EU MDR conformity assessments.
Ready to Transform Your Industry R&D?
Join the specialized life science leaders who are moving from fragmented data to digital excellence.